(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCL9 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of CCL9 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CCL9 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCL9 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of CCL9 mRNA CTD PMID:19647056 and PMID:21404309 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CCL9 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CCL9 mRNA CTD PMID:16114106 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CCL9 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL9 mRNA CTD PMID:15667827 and PMID:19770486 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CCL9 mRNA CTD PMID:17982090 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 3-methylcholanthrene multiple interactions EXP 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL9 mRNA CTD PMID:23519560 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CCL9 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of CCL9 mRNA CTD PMID:37611474 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of CCL9 mRNA CTD PMID:19647056 and PMID:21404309 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CCL9 mRNA CTD PMID:19770486 aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL9 mRNA CTD PMID:37567420 all-trans-retinoic acid increases expression ISO CCL23 (Homo sapiens) 6480464 Tretinoin results in increased expression of CCL23 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO CCL23 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CCL23 mRNA CTD PMID:24449571 arsenous acid increases expression ISO CCL23 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CCL23 mRNA CTD PMID:15761015 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CCL9 mRNA CTD PMID:19770486 and PMID:20713471 benzo[a]pyrene increases methylation ISO CCL23 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CCL23 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO CCL23 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CCL23 promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of CCL9 mRNA CTD PMID:15674844 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCL9 mRNA CTD PMID:25594700 cadmium atom multiple interactions ISO CCL23 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL23 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO CCL23 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL23 mRNA CTD PMID:35301059 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of CCL9 mRNA CTD PMID:21542829 carbon nanotube increases expression ISO CCL23 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of CCL23 mRNA CTD PMID:29348435 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of CCL9 mRNA CTD PMID:25620056 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:21135415 more ... cetirizine multiple interactions EXP 6480464 [Cetirizine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of CCL23 protein CTD PMID:25020133 CGP 52608 multiple interactions ISO CCL23 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CCL23 gene] CTD PMID:28238834 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of CCL9 protein] CTD PMID:22341560 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CCL9 mRNA CTD PMID:32715474 choline multiple interactions EXP 6480464 [PANX1 gene mutant form affects the susceptibility to [Dietary Fats co-treated with Choline deficiency]] which results in decreased expression of CCL9 protein CTD PMID:29246445 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CCL9 mRNA CTD PMID:21151649 cisplatin increases expression ISO CCL23 (Homo sapiens) 6480464 Cisplatin results in increased expression of CCL23 mRNA CTD PMID:27594783 cobalt atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 crocidolite asbestos increases expression EXP 6480464 Asbestos more ... CTD PMID:21135415 more ... cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CCL9 mRNA CTD PMID:21041162 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CCL9 mRNA CTD PMID:22334560 D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL9 mRNA CTD PMID:37567420 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CCL9 mRNA CTD PMID:21041162 dexamethasone multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL9 mRNA CTD PMID:29950665 dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of CCL9 mRNA CTD PMID:35093514 diarsenic trioxide increases expression ISO CCL23 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CCL23 mRNA CTD PMID:15761015 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CCL9 mRNA CTD PMID:26934552 diethyl malate affects expression EXP 6480464 diethyl malate affects the expression of CCL9 mRNA CTD PMID:24814887 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CCL9 mRNA CTD PMID:21041162 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL9 mRNA CTD PMID:30529165 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CCL9 mRNA CTD PMID:22334560 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of CCL9 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CCL9 mRNA CTD PMID:19167417 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCL9 mRNA CTD PMID:22206623 fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL9 mRNA CTD PMID:37567420 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CCL9 mRNA CTD PMID:32186404 glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL9 mRNA CTD PMID:37567420 graphene oxide increases expression EXP 6480464 graphene oxide results in increased expression of CCL9 mRNA CTD PMID:33227293 griseofulvin affects expression EXP 6480464 Griseofulvin affects the expression of CCL9 mRNA CTD PMID:12735108 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of CCL9 mRNA CTD PMID:20003209 lipopolysaccharide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL9 mRNA] more ... CTD PMID:22225513 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CCL9 mRNA CTD PMID:22225513 and PMID:26582142 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL9 mRNA] CTD PMID:22225513 medroxyprogesterone acetate increases expression ISO CCL23 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of CCL23 mRNA CTD PMID:20843944 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL9 mRNA] CTD PMID:22225513 methidathion increases expression EXP 6480464 methidathion results in increased expression of CCL9 mRNA CTD PMID:34813904 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CCL9 mRNA CTD PMID:24213012 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of CCL9 mRNA CTD PMID:37342990 monosodium L-glutamate multiple interactions EXP 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CCL9 mRNA CTD PMID:22078008 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CCL9 mRNA CTD PMID:25566086 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of CCL9 mRNA CTD PMID:18978301 nickel atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 nickel dichloride increases secretion ISO CCL23 (Homo sapiens) 6480464 nickel chloride results in increased secretion of CCL9 protein CTD PMID:18437699 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CCL9 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CCL9 mRNA CTD PMID:11264010 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCL9 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CCL9 mRNA CTD PMID:36331819 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CCL9 mRNA CTD PMID:19270015 more ... phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL9 mRNA CTD PMID:23519560 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CCL9 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CCL9 mRNA CTD PMID:28903501 progesterone affects expression EXP 6480464 Progesterone affects the expression of CCL9 mRNA CTD PMID:17251523 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CCL9 mRNA CTD PMID:21278054 and PMID:22334560 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL9 mRNA] CTD PMID:22225513 serpentine asbestos increases expression EXP 6480464 Asbestos and Serpentine results in increased expression of CCL9 mRNA CTD PMID:16251409 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CCL9 mRNA CTD PMID:23221170 and PMID:29341224 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CCL9 mRNA CTD PMID:37682722 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CCL9 mRNA and Carbon Tetrachloride results in increased expression of CCL9 protein CTD PMID:17484886 more ... tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CCL9 mRNA CTD PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CCL9 mRNA CTD PMID:21259345 more ... titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL9 mRNA CTD PMID:29950665 TMC-120A increases expression EXP 6480464 TMC 120A results in increased expression of CCL9 mRNA CTD PMID:19818335 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of CCL9 mRNA CTD PMID:19647056 and PMID:21404309 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of CCL9 mRNA CTD PMID:29279043 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CCL9 mRNA CTD PMID:16141432 and PMID:19042947 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CCL9 mRNA CTD PMID:28973697 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL9 mRNA] CTD PMID:22225513 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL9 mRNA] CTD PMID:23503329 zoledronic acid increases expression ISO CCL23 (Homo sapiens) 6480464 Zoledronic Acid results in increased expression of CCL23 mRNA CTD PMID:24714768
